Table 2.
Interventional and clinical outcome in patients with tandem occlusions treated using the antegrade vs. retrograde approach.
| Antegrade approach (n = 46) | Retrograde approach (n = 75) | P | |
|---|---|---|---|
| INTERVENTIONAL | |||
| Age (years) | 70 (63–79) | 70 (63–76) | 0.871 |
| Sex, female | 32.6% (15/46) | 21.3% (16/31) | 0.200 |
| Admission NIHSS | 18 (13–21) | 16 (10–19) | 0.077 |
| Procedure time | 95 (IQR 53–141) | 82 (IQR 61–109) | 0.251 |
| Number of maneuvers | 2 (IQR 1–3) | 1 (IQR 1–2) | 0.017 |
| Intracranial final TICI 2b/3 | 65.2% (30/46) | 73.3% (55/75) | 0.414 |
| Complications | 0.305 | ||
| - None - Dissection - Perforation - Other |
- 89.1% (41/46) - 10.9% (5/56) - 0% (0/46) - 0% (0/46) |
- 89.3% (67/75) - 5.3% (4/75) - 4.0% (3/75) - 1.3% (1/75) |
|
| Infarct in previously unaffected territories | 13.0% (6/46) | 4.0% (3/75) | 0.082 |
| sICH | 10.9% (5/46) | 10.7% (8/75) | 1.000 |
| aICH | 28.3% (13/46) | 30.7% (23/75) | 0.840 |
| Rethrombosis during acute treatment | 4.3% (2/46) | 9.3% (7/75) | 0.480 |
| ICA patency at end of procedure | 100% (46/46) | 97.3% (73/75) | 0.525 |
| ICA patency at day 7 | 93.5% (43/46) | 85.1% (63/74) | 0.244 |
| 90-day mRS | 3 (IQR 1–4) | 3 (IQR 1–5) | 0.300 |
| 90-day mRS ≤ 2 | 46.7% (21/45) | 39.7% (29/73) | 0.565 |
| 90-day mortality | 15.6% (7/45) | 21.9% (16/73) | 0.478 |